Fate Therapeutics raises $30M from financing round


Fate Therapeutics said it has raised $30 million from a series B funding round headed by OVP Venture Partners. The company is studying a method that employs small molecule drugs to turn adult stem cells into induced pluripotent stem cells.  San Diego Business Journal

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s